Kowal Investment Group’s Gilead Sciences GILD Stock Holding History

Kowal Investment Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$366K	Sell	4,363 -21	-0.5%	-$1.6K	0.07%	144
2024 Q2	$301K	Buy	4,384 +176	+4%	+$11.7K	0.06%	139
2024 Q1	$308K	Sell	4,208 -315	-7%	-$24.2K	0.07%	133
2023 Q4	$366K	Buy	4,523 +21	+0.5%	+$1.63K	0.09%	109
2023 Q3	$337K	Buy	4,502 +151	+3%	+$11.6K	0.09%	102
2023 Q2	$335K	Sell	4,351 -5	-0.1%	-$399	0.09%	112
2023 Q1	$361K	Buy	4,356 +276	+7%	+$22.9K	0.1%	97
2022 Q4	$350K	Buy	4,080 +535	+15%	+$42.4K	0.1%	105
2022 Q3	$219K	Buy	+3,545	New	+$224K	0.07%	125
2021 Q4	–	Sell	-269	Closed	-$19K	–	435
2021 Q3	$19K	Buy	+269	New	+$18.9K	0.01%	394

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Kowal Investment Group's GILD Position: Q3 2024 in Review

Kowal Investment Group reduced its Gilead Sciences (GILD) stake by 0.48% in Q3 2024, selling an estimated $1.6K and leaving 4,363 shares worth $366K. The position accounts for 0.07% of the portfolio, ranked #144.

Kowal Investment Group first reported a position in GILD in Q3 2021 and has held it in 10 quarters since. The position peaked at $366K in Q4 2023. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Kowal Investment Group held 4,363 shares of Gilead Sciences worth $366K as of Q3 2024.
Kowal Investment Group sold 21 Gilead Sciences shares in Q3 2024, an estimated $1.6K.
Gilead Sciences made up 0.07% of Kowal Investment Group's portfolio in Q3 2024, its #144 holding.
Kowal Investment Group first reported a position in Gilead Sciences in Q3 2021 and has held it in 10 quarters since.
Kowal Investment Group's Gilead Sciences position peaked at $366K in Q4 2023.
1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Kowal Investment Group's 13F filing for Q3 2024, filed 16 Oct 2024.